Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Chung Chang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|October 7, 2020
Equipment Anomaly Detection for Semiconductor Manufacturing by Exploiting Unsupervised Learning from Sensory DataChieh-Yu Chen, Shi-Chung Chang, Da-Yin Liao
Chang Gung Medical Journal|February 10, 2004
Interstitial laser photocoagulation for treatment of benign prostatic hypertrophy: outcomes and cost effectivenessKe-Hung Tsui, Phei-Lang Chang, Stanley Shi-Chung Chang, et al.
International Journal of Cancer|August 14, 2012
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic miceWei-Hsiang Lin, Shiou-Hwei Yeh, Wan-Jen Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2026
Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunityChang-Jung Chen, Hao-Chen Wang, Wen-Yen Huang, et al.
Scientific Reports|March 16, 2019
An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B CellsCheng-Chung Lee, Chih-Ya Yang, Li-Ling Lin, et al.
Journal of Biomedical Science|January 8, 2020
Structural basis of polyethylene glycol recognition by antibodyCheng-Chung Lee, Yu-Cheng Su, Tzu-Ping Ko, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 1, 2019
The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trialAristine Cheng, Szu-Min Hsieh, Sung-Ching Pan, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology|August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceChun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|October 7, 2020
Equipment Anomaly Detection for Semiconductor Manufacturing by Exploiting Unsupervised Learning from Sensory DataChieh-Yu Chen, Shi-Chung Chang, Da-Yin Liao
Chang Gung Medical Journal|February 10, 2004
Interstitial laser photocoagulation for treatment of benign prostatic hypertrophy: outcomes and cost effectivenessKe-Hung Tsui, Phei-Lang Chang, Stanley Shi-Chung Chang, et al.
International Journal of Cancer|August 14, 2012
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic miceWei-Hsiang Lin, Shiou-Hwei Yeh, Wan-Jen Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2026
Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunityChang-Jung Chen, Hao-Chen Wang, Wen-Yen Huang, et al.
Scientific Reports|March 16, 2019
An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B CellsCheng-Chung Lee, Chih-Ya Yang, Li-Ling Lin, et al.
Journal of Biomedical Science|January 8, 2020
Structural basis of polyethylene glycol recognition by antibodyCheng-Chung Lee, Yu-Cheng Su, Tzu-Ping Ko, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 1, 2019
The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trialAristine Cheng, Szu-Min Hsieh, Sung-Ching Pan, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology|August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceChun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Pageof 1